Compile Data Set for Download or QSAR
Found 90 Enz. Inhib. hit(s) with all data for entry = 50036489
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051280(CHEMBL544436 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 0.620nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051285(CHEMBL542554 | {4-[4-(4-Benzo[d]isothiazol-3-yl-pi...)copy SMILEScopy InChI
Affinity DataIC50: 0.700nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051286(CHEMBL544434 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051277(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 1.20nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051257(CHEMBL545607 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 1.40nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051259(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051265(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051265(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051284(2-Azido-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 3.70nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM85048(CHEMBL537481 | Glaxo 1192U90)copy SMILEScopy InChI
Affinity DataIC50: 3.80nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051273(CHEMBL554954 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 3.80nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051252(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051252(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051246(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 4.10nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051263(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 4.20nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051283(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 4.20nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051266((R)-2-{2-[4-(4-Benzo[d]isothiazol-3-yl-piperazin-1...)copy SMILEScopy InChI
Affinity DataIC50: 4.30nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051256(CHEMBL556030 | {3-[4-(4-Benzo[d]isothiazol-3-yl-pi...)copy SMILEScopy InChI
Affinity DataIC50: 4.40nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051255(CHEMBL539740 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 4.70nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051247(CHEMBL542310 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 5.20nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051288(2-Acetylamino-N-[4-(4-benzo[d]isothiazol-3-yl-pipe...)copy SMILEScopy InChI
Affinity DataIC50: 5.20nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051281((S)-2-{2-[4-(4-Benzo[d]isothiazol-3-yl-piperazin-1...)copy SMILEScopy InChI
Affinity DataIC50: 5.40nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051251(CHEMBL542058 | {2-[4-(4-Benzo[d]isothiazol-3-yl-pi...)copy SMILEScopy InChI
Affinity DataIC50: 5.40nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051251(CHEMBL542058 | {2-[4-(4-Benzo[d]isothiazol-3-yl-pi...)copy SMILEScopy InChI
Affinity DataIC50: 5.60nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051253(CHEMBL544908 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 5.80nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051258(CHEMBL553382 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 6.40nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051244(3-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 6.60nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051246(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 7.80nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051266((R)-2-{2-[4-(4-Benzo[d]isothiazol-3-yl-piperazin-1...)copy SMILEScopy InChI
Affinity DataIC50: 8.60nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051279(CHEMBL537036 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051272(CHEMBL538972 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 9.10nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051249(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 9.40nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051270(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051255(CHEMBL539740 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051264(CHEMBL544206 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 11nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051256(CHEMBL556030 | {3-[4-(4-Benzo[d]isothiazol-3-yl-pi...)copy SMILEScopy InChI
Affinity DataIC50: 12nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051253(CHEMBL544908 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 12nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051260(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 12nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051249(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051262(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051250(CHEMBL545144 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051259(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051285(CHEMBL542554 | {4-[4-(4-Benzo[d]isothiazol-3-yl-pi...)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051258(CHEMBL553382 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051282(CHEMBL545373 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051283(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051263(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051257(CHEMBL545607 | N-[4-(4-Benzo[d]isothiazol-3-yl-pip...)copy SMILEScopy InChI
Affinity DataIC50: 17nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051260(2-Amino-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 18nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Glaxo Wellcome Inc.

Curated by ChEMBL
LigandPNGBDBM50051284(2-Azido-N-[4-(4-benzo[d]isothiazol-3-yl-piperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 19nMAssay Description:In vitro inhibitory activity against [3H]raclopride binding to dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2SQ912QPubMed
Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: